Literature DB >> 26451313

Restoring inflammatory balance as a potential preventive strategy for inflammation induced cancer.

Simona Hefetz-Sela1, Ilan Stein2, Eli Pikarsky2.   

Abstract

In contrast to the accepted notion that tumor-derived signals polarize macrophages toward a protumorigenic M2 phenotype during tumor progression, we recently discovered that the inflammatory microenvironment is capable of driving macrophages toward an M2 phenotype. Moreover, our data suggests that inflammatory education is prominent during the early phases of hepatocellular carcinoma (HCC) suggesting that inflammatory modulation might effectively prevent HCC.

Entities:  

Keywords:  c-Jun phosphorylation; hepatocellular carcinoma; immune check point drugs; inflammation-induced cancer; macrophage polarization

Year:  2015        PMID: 26451313      PMCID: PMC4589047          DOI: 10.1080/2162402X.2015.1039764

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  10 in total

Review 1.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 2.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

3.  Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation.

Authors:  Simona Hefetz-Sela; Ilan Stein; Yair Klieger; Rinnat Porat; Moshe Sade-Feldman; Farid Zreik; Arnon Nagler; Orit Pappo; Luca Quagliata; Eva Dazert; Robert Eferl; Luigi Terracciano; Erwin F Wagner; Yinon Ben-Neriah; Michal Baniyash; Eli Pikarsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 4.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 5.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

6.  CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.

Authors:  Yoshiki Mizukami; Koji Kono; Yoshihiko Kawaguchi; Hidenori Akaike; Kazuyasu Kamimura; Hidemitsu Sugai; Hideki Fujii
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

7.  Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.

Authors:  Oscar R Colegio; Ngoc-Quynh Chu; Alison L Szabo; Thach Chu; Anne Marie Rhebergen; Vikram Jairam; Nika Cyrus; Carolyn E Brokowski; Stephanie C Eisenbarth; Gillian M Phillips; Gary W Cline; Andrew J Phillips; Ruslan Medzhitov
Journal:  Nature       Date:  2014-07-13       Impact factor: 69.504

8.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

Authors:  Stephanie M Pyonteck; Leila Akkari; Alberto J Schuhmacher; Robert L Bowman; Lisa Sevenich; Daniela F Quail; Oakley C Olson; Marsha L Quick; Jason T Huse; Virginia Teijeiro; Manu Setty; Christina S Leslie; Yoko Oei; Alicia Pedraza; Jianan Zhang; Cameron W Brennan; James C Sutton; Eric C Holland; Dylan Daniel; Johanna A Joyce
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

Review 9.  Tumor-associated macrophages as major players in the tumor microenvironment.

Authors:  Theerawut Chanmee; Pawared Ontong; Kenjiro Konno; Naoki Itano
Journal:  Cancers (Basel)       Date:  2014-08-13       Impact factor: 6.639

Review 10.  The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.

Authors:  L Bingle; N J Brown; Claire E Lewis
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

  10 in total
  1 in total

1.  Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer.

Authors:  Kimberly A Silverio; Shyam A Patel
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.